Sign in

CIK 0000943819 · Large accelerated filer

RESMED INC

Sign in to watch
Tickers
RMD RSMDF
Exchange
NYSE, OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
980152841
Phone
8587462400
Business address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123

Securities

  • RMD ResMed Inc. Common Stock NYSE
  • RSMDF Common stock OTC
  1. 4 Planned sale Chairman and CEO sold 4,993 shares at $235.35 ($1,175,089)
  2. 4 Planned sale Global General Counsel sold 400 shares at $255.00 ($102,000)
  3. 4 Planned sale Chairman and CEO sold 4,991 shares at $226.33 ($1,129,637)
  4. 4/A Insider Changes in Ownership
  5. 4 Grant or award Chief Product Officer acquired 6,461 shares (grant or award)
  6. 4 Grant or award Global General Counsel acquired 3,230 shares (grant or award)
  7. 4 Grant or award Chairman and CEO acquired 13,547 shares (grant or award)
  8. 4 Grant or award Chief Financial Officer acquired 9,072 shares (grant or award)
  9. 4 Planned sale Chairman and CEO sold 4,991 shares at $222.44 ($1,110,191)
  10. 4 Planned sale Director sold 970 shares at $234.73 ($227,688)
  11. 4 Planned sale Chairman and CEO sold 4,991 shares at $205.69 ($1,026,596)
  12. 4 Planned sale Director sold 8,000 shares at $225.00 ($1,800,000)
  13. 4 Planned sale Chairman and CEO sold 4,991 shares at $218.55 ($1,090,771)
  14. 4 Planned sale Chairman and CEO sold 4,991 shares at $193.96 ($968,064)
  15. 4 Shares withheld for taxes Global General Counsel gave up 268.74 shares (to pay taxes)
  16. 4 Planned sale Chairman and CEO sold 4,991 shares at $207.82 ($1,037,233)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Planned sale Chairman and CEO sold 4,991 shares at $225.50 ($1,125,486)
  20. 4 Planned sale Chief Financial Officer sold 1,000 shares at $224.31 ($224,310)

Page 1 of 92 · 1,827 filings